duvortuxizumab
Showing 1 - 1 of 1
Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial (Duvortuxizumab, Ibrutinib)
Withdrawn
- Leukemia, Lymphocytic, Chronic, B-Cell
- +3 more
- Duvortuxizumab
- Ibrutinib
- (no location specified)
Nov 22, 2017